Gennex Laboratories

Gennex Laboratories EPS

The Earnings per Share (EPS) of Gennex Laboratories (531739.BO) as of Oct 19, 2026 is 0.86 INR. In the previous year, Earnings per Share (EPS) was 0.75 INR — a change of 15.76% (higher).

EPS

0.86INR

YoY

15.76%

Last updated:

Earnings per Share (EPS) of Gennex Laboratories is 2026 0.86 INR. Earnings per Share (EPS) of Gennex Laboratories was 2025 0.75 INR. It decreases by 15.76% higher compared to the previous year.

The Gennex Laboratories EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
0.09 INR
Jan 1, 2020
0.08 INR
Jan 1, 2021
0.17 INR
Jan 1, 2022
0.16 INR
Jan 1, 2023
0.20 INR
Jan 1, 2024
0.54 INR
Jan 1, 2025
0.75 INR
Jan 1, 2026
0.86 INR
The Gennex Laboratories EPS history
YEAREPSYoY
0.86INR+15.76%
0.75INR+37.55%
0.54INR+167.74%
0.20INR+25.43%
0.16INR-2.85%
0.17INR+117.53%
0.08INR-16.41%
0.09INR+165.71%
0.03INR-83.91%
0.21INR+15.77%
0.18INR+586.04%
0.03INR+217.17%
0.01INR-73.16%
0.03INR+5.26%
0.03INR-7.32%
0.03INR-158.57%
-0.06INR-337.94%
0.02INR-56.74%
0.05INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gennex Laboratories Stock analysis

What does Gennex Laboratories do? Gennex Laboratories Ltd is a pharmaceutical manufacturer headquartered in Hyderabad, India, listed on the stock exchange in 1996. The company operates through its Pharmaceutical Products segment, specializing in the production of bulk drugs, intermediates, and biotech products. Its robust portfolio includes active pharmaceutical ingredients such as Guaifenesin, Methocarbamol, Phenazopyridine Hcl, Fluconazole, Mephenesin, Chlorphenesin, and Melitracen Hcl. These products serve various therapeutic areas, including expectorants, muscle relaxants, analgesics, anti-fungals, and antidepressants. Gennex Laboratories utilizes manufacturing facilities in India to supply both domestic and international markets, catering to the global demand for essential healthcare solutions within the health care sector. Gennex Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gennex Laboratories stock

Earnings per Share (EPS) of Gennex Laboratories is 0.86 INR in 2026.

Earnings per Share (EPS) of Gennex Laboratories changed from 0.75 INR to 0.86 INR, representing a 15.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Gennex Laboratories since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Gennex Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Gennex Laboratories